Suppr超能文献

腺苷A1受体介导的对大鼠纹状体切片中多巴胺释放的抑制作用受D1多巴胺受体的调节。

Adenosine A1 receptor-mediated inhibition of dopamine release from rat striatal slices is modulated by D1 dopamine receptors.

作者信息

O'Neill C, Nolan B J, Macari A, O'Boyle K M, O'Connor J J

机构信息

UCD School of Biomolecular and Biomedical Science, Conway Institute of Biomolecular and Biomedical Research, Belfield Dublin 4, Ireland.

出版信息

Eur J Neurosci. 2007 Dec;26(12):3421-8. doi: 10.1111/j.1460-9568.2007.05953.x. Epub 2007 Dec 4.

Abstract

Dopamine release is regulated by presynaptic dopamine receptors and interactions between adenosine and dopamine receptors have been well documented. In the present study, dopamine release from isolated striatal slices from Wistar rats was measured using fast cyclic voltammetry. Single-pulse stimulation (0.1 ms, 10 V) was applied every 5 min over a 2-h period. Superfusion with the adenosine (A)(1) receptor agonist N(6)-cyclopentyladenosine (CPA), but not the A(2) receptor agonist 3-[4-[2-[[6-amino-9-[(2R,3R,4S,5S)-5-(ethylcarbamoyl)-3,4-dihydroxy-oxolan-2-yl]purin-2-yl]amino]ethyl] phenyl]propanoic acid (CGS 21680), inhibited dopamine release in a concentration-dependent manner (IC(50) 3.80 x 10(-7) m; n = 10). The dose-response curve to CPA was shifted to the right (IC(50) 6.57 x 10(-6) m; n = 6, P < 0.05 vs. control) by the A(1) receptor antagonist 8-cyclopentyl-1,3-dipropylxanthine (DPCPX). Neither the D(1) agonist 6-chloro-APB nor the D(1) antagonist R-(+)-8-chloro-2,3,4,5-tetrahydro-3-methyl-5-phenyl-1H-3- benzazepine-7-ol (SCH 23390) altered dopamine release on their own. However, SCH 23390 (3 microm) significantly attenuated the response to CPA (IC(50) 1.44 x 10(-5) m; n = 6, P < 0.01 vs. control). Furthermore, the inhibitory effect of CPA was significantly increased in the presence of 6-chloro-APB (1 microm). In radioligand binding experiments, CPA interacted with high- and low-affinity states of [(3)H]DPCPX-lableled A(1) receptors. The high-affinity agonist binding to A(1) receptors was inhibited by the stable guanosine triphosphate analogue Gpp(NH)p. In contrast, neither the proportion nor the affinity of high-affinity A(1) receptors was altered by dopamine or SCH 23390. These results provide evidence that the inhibition of dopamine release by adenosine A(1) receptors is dependent, at least in part, on the simultaneous activation of D(1) dopamine receptors. While the mechanism underlying this interaction remains to be determined, it does not appear to involve an intramembrane interaction between A(1) and D(1) receptors.

摘要

多巴胺释放受突触前多巴胺受体调控,腺苷与多巴胺受体之间的相互作用已有充分记载。在本研究中,采用快速循环伏安法测定了Wistar大鼠离体纹状体切片中的多巴胺释放。在2小时内,每隔5分钟施加一次单脉冲刺激(0.1毫秒,10伏)。用腺苷A(1)受体激动剂N(6)-环戊基腺苷(CPA)进行灌流,但不是A(2)受体激动剂3-[4-[2-[[6-氨基-9-[(2R,3R,4S,5S)-5-(乙基氨基甲酰)-3,4-二羟基-氧杂环戊烷-2-基]嘌呤-2-基]氨基]乙基]苯基]丙酸(CGS 21680),以浓度依赖方式抑制多巴胺释放(IC(50) 3.80×10(-7) 米;n = 10)。A(1)受体拮抗剂8-环戊基-1,3-二丙基黄嘌呤(DPCPX)使CPA的剂量反应曲线右移(IC(50) 6.57×10(-6) 米;n = 6,与对照组相比P < 0.05)。D(1)激动剂6-氯-APB和D(1)拮抗剂R-(+)-8-氯-2,3,4,5-四氢-3-甲基-5-苯基-1H-3-苯并氮杂卓-7-醇(SCH 23390)单独使用时均未改变多巴胺释放。然而,SCH 23390(3微摩尔)显著减弱了对CPA的反应(IC(50) 1.44×10(-5) 米;n = 6,与对照组相比P < 0.01)。此外,在6-氯-APB(1微摩尔)存在时,CPA的抑制作用显著增强。在放射性配体结合实验中,CPA与[(3)H]DPCPX标记的A(1)受体的高亲和力和低亲和力状态相互作用。与A(1)受体的高亲和力激动剂结合被稳定的鸟苷三磷酸类似物Gpp(NH)p抑制。相反,多巴胺或SCH 23390既未改变高亲和力A(1)受体的比例,也未改变其亲和力。这些结果提供了证据,表明腺苷A(1)受体对多巴胺释放的抑制至少部分依赖于D(1)多巴胺受体的同时激活。虽然这种相互作用的潜在机制仍有待确定,但似乎不涉及A(1)和D(1)受体之间的膜内相互作用。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验